Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.

about

Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q38406220

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical validity of Metrotick ...... for hepatocellular carcinoma.

@en

type

Item

label

Clinical validity of Metrotick ...... for hepatocellular carcinoma.

@en

prefLabel

Clinical validity of Metrotick ...... for hepatocellular carcinoma.

@en

P1476

Clinical validity of Metrotick ...... for hepatocellular carcinoma.

@en

P2093

Deok-Bog Moon

http://www.w3.org/2001/XMLSchema#string

Eunsil Yu

http://www.w3.org/2001/XMLSchema#string

Gi-Won Song

http://www.w3.org/2001/XMLSchema#string

Gi-Young Ko

http://www.w3.org/2001/XMLSchema#string

Han Chu Lee

http://www.w3.org/2001/XMLSchema#string

Hyung-Don Kim

http://www.w3.org/2001/XMLSchema#string

Kang Mo Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Bo Sung

http://www.w3.org/2001/XMLSchema#string

Seungbong Han

http://www.w3.org/2001/XMLSchema#string

Shin Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma.

Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.

Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.

The place of downstaging for hepatocellular carcinoma.

P2888

s12072-017-9785-2

P304

209-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-017-9785-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ju Hyun Shim

Jihyun An

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083400221

http://www.w3.org/2001/XMLSchema#string

P698

28144812

http://www.w3.org/2001/XMLSchema#string